TY - JOUR T1 - Cholesterol atheroembolism and combined treatment with steroids and iloprost JO - Nefrología (English Edition) T2 - AU - Sevillano Prieto,Angel Manuel AU - Sevillano-Prieto,Ángel M. AU - Hernández Martínez,Eduardo AU - Hernández-Martínez,Eduardo AU - Caro Espada,Jara AU - Caro-Espada,Jara AU - Molina Gomez,Maria AU - Molina-Gómez,María AU - Gutiérrez Martínez,Eduardo AU - Gutiérrez-Martínez,Eduardo AU - Morales Ruiz,Enrique AU - Morales-Ruiz,Enrique AU - Gonzalez Monte,Ester AU - González-Monte,Ester AU - Praga Terente,Manuel AU - Praga-Terente,Manuel SN - 20132514 M3 - 10.3265/Nefrologia.pre2012.Aug.11645 DO - 10.3265/Nefrologia.pre2012.Aug.11645 UR - https://revistanefrologia.com/en-cholesterol-atheroembolism-combined-treatment-with-articulo-X2013251412002221 AB - Cholesterol atheroembolism (CAE) is a systemic disorder whose incidence has increased in recent decades and that presents high morbidity and mortality. Although several therapeutic alternatives have been reported, there is no consensus about the best treatment for this disease. In this paper we report the case of a patient with CAE with skin, bowel and kidney involvement who presented a good response to combined therapy with steroids and prostaglandin analogues. Although there are no conclusive studies, we recommend this therapeutic alternative in the management of CAE with organic failure. ER -